Q1 FY27: Tega posts strong standalone growth, Molycop deal costs weigh
TEGA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts more than Nifty Smallcap 250 and 1.8 pts more than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone revenue grew 60% YoY to 2,686.54 million rupees; PAT up 18% to 454.20 million. Consolidated revenue jumped to 17,234.42 million but logged a loss of 1,082.52 million due to 1,909.55 million one-time Molycop deal expenses and higher finance costs of 1,167 million. Molycop acquisition closed June 1, 2026 for 41,907 million (US$442.7 million); contributed about 12,916 million in one month of revenue.
Standalone results steady; consolidated loss is from one-time Molycop deal costs. Watch debt servicing and synergy delivery.